checkAd

    DGAP-News  129  0 Kommentare Abivax 2021 Financial Communication Calendar

    DGAP-News: ABIVAX / Key word(s): Miscellaneous
    Abivax 2021 Financial Communication Calendar

    03.12.2020 / 18:00
    The issuer is solely responsible for the content of this announcement.


    Abivax 2021 Financial Communication Calendar


    PARIS, FRANCE, December 3, 2020 - 6:00 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today publishes its 2021 financial communication calendar.

    • Thursday, April 1, 2021
      Publication of financial statements as of December 31, 2020
       
    • Friday, April 30, 2021
      Publication and release of the 2020 annual financial report
       
    • Friday, June 4, 2021 - 10.00 a.m.
      Shareholders meeting
       
    • Thursday, September 23, 2021
      Publication of financial statements as of June 30, 2021
       
    • Thursday, September 30, 2021
      Publication and release of 2021 half year report


    About Abivax (www.abivax.com)
    Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with chronic inflammatory diseases, viral infections, and cancer. Abivax is listed on Euronext compartment C (ISIN: FR0012333284 - Mnémo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical development, ABX464 to treat severe inflammatory diseases, and ABX196 to treat hepatocellular carcinoma. More information on the company is available at www.abivax.com. Follow us on Twitter @ABIVAX_.


    Contacts

    Abivax
    Communications
    Regina Jehle
    regina.jehle@abivax.com
    +33 6 24 50 69 63
    Investors
    LifeSci Advisors
    Chris Maggos
    chris@lifesciadvisors.com
    +41 79 367 6254
    Press Relations & Investors Europe
    MC Services AG
    Anne Hennecke
    anne.hennecke@mc-services.eu
    +49 211 529 252 22
    Public Relations France
    Actifin
    Ghislaine Gasparetto
    ggasparetto@actifin.fr
    +33 6 21 10 49 24
    Public Relations France
    DGM Conseil
    Thomas Roborel de Climens
    thomasdeclimens@dgm-conseil.fr
    +33 6 14 50 15 84
    Public Relations USA
    Rooney Partners LLC
    Marion Janic
    mjanic@rooneyco.com
    +1 212 223 4017


    03.12.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    1152398  03.12.2020 

    fncls.ssp?fn=show_t_gif&application_id=1152398&application_name=news&site_id=wallstreet

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Abivax 2021 Financial Communication Calendar DGAP-News: ABIVAX / Key word(s): Miscellaneous Abivax 2021 Financial Communication Calendar 03.12.2020 / 18:00 The issuer is solely responsible for the content of this announcement. Abivax 2021 Financial Communication Calendar PARIS, FRANCE, …

    Schreibe Deinen Kommentar

    Disclaimer